Look on the bright side. It's a clear endorsement for the drug's efficacy. If they are willing to pay US$1350 for a vet product, what would they pay for a FDA-approved product recommended by their doctor? I don't think he would be doing this if there was an approved option available, ie. clear evidence of unmet need. You have to trust 99% of doctors to do the right thing. It'll eventually come out of the government/insurer's pocket anyway, there would be no benefit to prescribe their patient with a black market option.
research reports and media, page-720
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |